Sugen–morphine model of pulmonary arterial hypertension

Sugen–morphine model of pulmonary arterial hypertension

Pulmonary arterial hypertension is a fatal disease associated with pulmonary vascular remodeling and right ventricular hypertrophy. Pre-clinical animal models that reproduce the human pulmonary arterial hypertension process and pharmacological response to available therapies are critical for future...

Full description

Bibliographic Details
Main Authors:	Stuti Agarwal, Zachery J. Harter, Balaji Krishnamachary, Ling Chen, Tyler Nguyen, Norbert F. Voelkel, Navneet K. Dhillon
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-01-01
Series:	Pulmonary Circulation
Online Access:	https://doi.org/10.1177/2045894019898376

Similar Items

Sugen, hypoxia and the lung circulation
by: Norbert F. Voelkel, et al.
Published: (2021-10-01)

Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension.
by: Aysar Al-Husseini, et al.
Published: (2015-01-01)

TRAIL Deficient Mice Are Protected from Sugen/Hypoxia Induced Pulmonary Arterial Hypertension
by: Sarah H. Dawson, et al.
Published: (2014-07-01)

The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
by: Yohei Honda, et al.
Published: (2020-01-01)

Direct Delivery of MicroRNA96 to the Lungs Reduces Progression of Sugen/Hypoxia-Induced Pulmonary Hypertension in the Rat
by: Craig K. Docherty, et al.
Published: (2020-12-01)

Understanding longitudinal biventricular structural and functional changes in a pulmonary hypertension Sugen–hypoxia rat model by cardiac magnetic resonance imaging
by: Geeshath Jayasekera, et al.
Published: (2020-01-01)

Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation
by: Sakao Seiichiro, et al.
Published: (2009-10-01)

The Effects of a Novel Endothelin Receptor Antagonist, Macitentan, on Right Ventricular Substrate Utilization and Function in a Sugen5416/Hypoxia Rat Model of Severe Pulmonary Artery Hypertension
by: Drozd, Katarzyna
Published: (2015)

A new treatment for severe pulmonary arterial hypertension based on an old idea: inhibition of 5-lipoxygenase
by: Norbert F. Voelkel, et al.
Published: (2020-03-01)

Targeting Neurohormonal Activation in Pulmonary Arterial Hypertension
by: Jose Gomez-Arroyo, MD, PhD, et al.
Published: (2017-02-01)

The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
by: Seiichiro Sakao, et al.
Published: (2014-09-01)

Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension
by: Sweeney Lori, et al.
Published: (2009-09-01)

The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
by: Wen Tian, et al.
Published: (2021-08-01)

Genomic approaches to research in pulmonary hypertension
by: Tuder Rubin M, et al.
Published: (2001-05-01)

Creation of a restrictive atrial communication in pulmonary arterial hypertension (PAH): effective palliation of syncope and end-stage heart failure
by: Anna Bauer, et al.
Published: (2018-06-01)

Fatal dissection of the pulmonary artery in pulmonary arterial hypertension
by: B. Degano, et al.
Published: (2009-09-01)

Schistosomiasis Pulmonary Arterial Hypertension
by: Jean Pierre Sibomana, et al.
Published: (2020-12-01)

Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
by: M. Humbert
Published: (2010-03-01)

The challenges in paediatric pulmonary arterial hypertension
by: Maurice Beghetti, et al.
Published: (2014-12-01)

The Exercise Capacity and Quality of Life in the Patients with Idiopathic Pulmonary Arterial Hypertension and Secondary Pulmonary Hypertension
by: Ling-Wei Chen, et al.
Published: (2016)

Identity crisis in pulmonary arterial hypertension
by: G. Ruffenach, et al.
Published: (2017-12-01)

Pulmonary Arterial Hypertension and Pregnancy
by: Shibba Takkar Chhabra, et al.
Published: (2018-08-01)

The arterial load in pulmonary hypertension
by: A. Vonk-Noordegraaf, et al.
Published: (2010-09-01)

Trends in pulmonary arterial hypertension
by: R. Souza, et al.
Published: (2009-03-01)

The revolution of pulmonary arterial hypertension
by: Sergio Harari
Published: (2016-12-01)

Pregnancy in pulmonary arterial hypertension
by: Karen M. Olsson, et al.
Published: (2016-12-01)

Pulmonary arterial hypertension and pregnancy
by: Demet Terek, et al.
Published: (2013-01-01)

Arrhythmias in pulmonary arterial hypertension
by: Ian Peter Temple
Published: (2017-06-01)

Echocardiography and Pulmonary Arterial Hypertension
by: Eduardo Bossone, et al.
Published: (2016-01-01)

Pulmonary Artery Hypertension in SLE
by: B. K. S. Sastry
Published: (2021-04-01)

Extracellular vesicle‐mediated endothelial apoptosis and EV‐associated proteins correlate with COVID‐19 disease severity
by: Balaji Krishnamachary, et al.
Published: (2021-07-01)

The isobaric pulmonary arterial compliance in pulmonary hypertension
by: Denis Chemla, et al.
Published: (2021-05-01)

The Significance of Pulmonary Artery Size in Pulmonary Hypertension
by: Kamonpun Ussavarungsi, et al.
Published: (2014-07-01)

Demographics, epidemiology and prognostic factors in pulmonary arterial hypertension
by: Ling, Yi
Published: (2014)

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
by: Thomas Koudstaal, et al.
Published: (2020-02-01)

Dynamic right ventricular–pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension
by: Inderjit Singh, et al.
Published: (2019-07-01)

Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study
by: Huber Lars C, et al.
Published: (2008-02-01)

Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension
by: Wei Sun, et al.
Published: (2018-07-01)

Metabolomics of exercise pulmonary hypertension are intermediate between controls and patients with pulmonary arterial hypertension
by: Jason L. Sanders, et al.
Published: (2019-10-01)

“Anagrelide-induced pulmonary arterial hypertension”: a rare case of drug-induced pulmonary arterial hypertension
by: Keiko Sumimoto, et al.
Published: (2019-12-01)